Search Result

Results for "

Antidiabetic properties

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Adenosine Receptor (1) Akt (2) AMPK (4) Amylin Receptor (1) Apoptosis (9) Autophagy (3) Bacterial (6) Cannabinoid Receptor (1) CGRP Receptor (1) COX (2) Cytochrome P450 (2) Endogenous Metabolite (9) Environmental Pollutants (1) ERK (4) Ferroptosis (2) Fungal (1) GLUT (2) Glycosidase (1) GSK-3 (2) HBV (1) Interleukin Related (2) Isotope-Labeled Compounds (1) JAK (2) JNK (4) Keap1-Nrf2 (2) NF-κB (6) NO Synthase (2) NOD-like Receptor (NLR) (1) p38 MAPK (4) Phosphatase (4) PKC (2) Potassium Channel (2) PPAR (5) Reactive Oxygen Species (ROS) (5) Reference Standards (9) SGLT (1) SOD (1) STAT (2) TGF-beta/Smad (2) Tyrosinase (3)
By Research Areas:	Cancer (17) Cardiovascular Disease (4) Endocrinology (4) Infection (7) Inflammation/Immunology (22) Metabolic Disease (32) Neurological Disease (9)

By Targets:

Adenosine Receptor (1)

Akt (2)

AMPK (4)

Amylin Receptor (1)

Apoptosis (9)

Autophagy (3)

Bacterial (6)

Cannabinoid Receptor (1)

CGRP Receptor (1)

COX (2)

Cytochrome P450 (2)

Endogenous Metabolite (9)

Environmental Pollutants (1)

ERK (4)

Ferroptosis (2)

Fungal (1)

GLUT (2)

Glycosidase (1)

GSK-3 (2)

HBV (1)

Interleukin Related (2)

Isotope-Labeled Compounds (1)

JAK (2)

JNK (4)

Keap1-Nrf2 (2)

NF-κB (6)

NO Synthase (2)

NOD-like Receptor (NLR) (1)

p38 MAPK (4)

Phosphatase (4)

PKC (2)

Potassium Channel (2)

PPAR (5)

Reactive Oxygen Species (ROS) (5)

Reference Standards (9)

SGLT (1)

SOD (1)

STAT (2)

TGF-beta/Smad (2)

Tyrosinase (3)

By Research Areas:

Cancer (17)

Cardiovascular Disease (4)

Endocrinology (4)

Infection (7)

Inflammation/Immunology (22)

Metabolic Disease (32)

Neurological Disease (9)

Inhibitors & Agonists

Peptides

Natural
Products

Isotope-Labeled Compounds

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-N0828

Pterostilbene 5+ Cited Publications	Autophagy	Inflammation/Immunology Cancer
Pterostilbene is a stilbenoid isolated from blueberries and Pterocarpus marsupium . Shows anti-oxidant, anti-inflammatory, anti-carcinogenic, anti-diabetic and anti-obesity properties . Pterostilbene blocks ROS production , also exhibits inhibitory activity against various free radicals such as DPPH, ABTS, hydroxyl, superoxide and hydrogen peroxide .

HY-N0457

Chicoric acid 2 Publications Verification Cichoric acid; Dicaffeoyltartaric acid	Reactive Oxygen Species (ROS) Apoptosis	Metabolic Disease Inflammation/Immunology
Chicoric acid (Cichoric acid), an orally active dicaffeyltartaric acid, induces reactive oxygen species (ROS) generation. Chicoric acid inhibits cell viability and induces mitochondria-dependent apoptosis in 3T3-L1 preadipocytes through ROS-mediated PI3K/Akt and MAPK signaling pathways. Chicoric acid increases glucose uptake, improves insulin resistance, and attenuates glucosamine-induced inflammation. Chicoric acid has antidiabetic properties and antioxidant, anti-inflammatory effects .

HY-N0036

Costunolide 5+ Cited Publications (+)-Costunolide; Costus lactone	Apoptosis Endogenous Metabolite	Cancer
Costunolide ((+)-Costunolide) is a naturally occurring sesquiterpene lactone, with antioxidative, anti-inflammatory, antiallergic, bone remodeling, neuroprotective, hair growth promoting, anticancer, and antidiabetic properties. Costunolide can induce cell cycle arrest and apoptosis on breast cancer cells .

HY-N0188

Esculin 5 Publications Verification	p38 MAPK	Inflammation/Immunology Cancer
Esculin is a fluorescent coumarin glucoside, the active ingredient in ash bark. Esculin has antidiabetic effects, improves cognitive impairment in experimental diabetic nephropathy (DN) via the MAPK signaling pathway, and exerts antioxidant stress and anti-inflammatory effects. Esculin also has anticancer, antibacterial, antiviral, neuroprotective, antithrombotic, and therapeutic properties for eye diseases .

HY-W013075

Rutin trihydrate Maximum Cited Publications 30 Publications Verification Rutoside trihydrate; Quercetin 3-O-rutinoside trihydrate	Apoptosis Endogenous Metabolite	Neurological Disease Cancer
Rutin (Rutoside) trihydrate is a multifunctional natural flavonoid glycoside. Rutin trihydrate has been demonstrating excellent antioxidant, anti-inflammatory, anti-diabetic, and anti-carcinogenic properties. Cardioprotective and neuroprotective activities .

HY-14621

Zingerone 5+ Cited Publications Vanillylacetone; Gingerone	Environmental Pollutants NF-κB	Neurological Disease Metabolic Disease Inflammation/Immunology Cancer
Zingerone (Vanillylacetone) is a nontoxic methoxyphenol isolated from Zingiber officinale, with potent anti-inflammatory, antidiabetic, antilipolytic, antidiarrhoeic, antispasmodic and anti-tumor properties . Zingerone alleviates oxidative stress and inflammation, down-regulates NF-κB mediated signaling pathways . Zingerone acts as an anti-mitotic agent, and inhibits the growth of neuroblastoma cells . Zingerone can cross the blood-brain barrier (BBB) .

HY-B0920

Tolazamide 2 Publications Verification U-17835	Potassium Channel	Metabolic Disease Endocrinology
Tolazamide (U-17835) is an orally active sulfonylurea agent that inhibits sulfonylurea receptor 1 (SUR1) linked to the inwardly rectifying potassium channel (IC₅₀ = 4.2 µM in HEK293 cells transfected with the human receptor). Tolazamide has anti-diabetic properties. Tolazamide can lower blood glucose in sulfonylurea class. Tolazamide decreases insulin dose while continuing to maintain adequate metabolic control. Tolazamide is able to improve or normalize hyperglycemia and HbA .

HY-N2189

Swertisin 2 Publications Verification	Adenosine Receptor HBV SGLT	Infection Neurological Disease Inflammation/Immunology
Swertisin is an oral adenosine A1 receptor antagonist and an SGLT2 inhibitor. Swertisin has anti-diabetic, antioxidant properties, inhibits HBV, and improves cognitive and memory impairments in mice .

HY-N2534

Karanjin 2 Publications Verification	AMPK Apoptosis Cytochrome P450 Phosphatase NF-κB	Neurological Disease Metabolic Disease Inflammation/Immunology Endocrinology Cancer
Karanjin is an orally active furanoflavonoid which can be isolated from several Leguminosae. Karanjin exhibits evident anti-diabetic, anti-cancer, anti-inflammatory, antioxidant, anticolitis, anti-ulcer, anti-Alzheimer properties and multiple insect repellent/insecticidal, acaricide properties, suggesting the potential of Karanjin to be applied to relevant research .

HY-14928

Lobeglitazone	PPAR ERK JNK TGF-beta/Smad NO Synthase COX NF-κB Interleukin Related	Cardiovascular Disease Metabolic Disease Inflammation/Immunology
Lobeglitazone is a new type of thiazolidinedione. Lobeglitazone is the orally active agonist for PPAR with EC₅₀ of 137.4 nM and 546.3 nM for PPARγ and PPARα. Lobeglitazone is the inhibitor for ERK/JNK/Smad/NF-κB signaling pathway. Lobeglitazone exhibits anti-inflammatory, anti-diabetic, anti-fibrotic and anti-atherosclerotic properties .

HY-100618

Hispidin 1 Publications Verification	PKC Endogenous Metabolite Ferroptosis Reactive Oxygen Species (ROS) p38 MAPK JAK STAT JNK Akt GSK-3 ERK Keap1-Nrf2	Cardiovascular Disease Metabolic Disease Inflammation/Immunology Cancer
Hispidin, a PKC inhibitor and a phenolic compound can be found in Phellinus linteus, has been shown to possess strong anti-oxidant, anti-cancer, anti-diabetic, and anti-dementia properties .

HY-N1394

p-Anisic acid 3 Publications Verification 4-Methoxybenzoic acid; Draconic acid	Bacterial Endogenous Metabolite Tyrosinase	Infection Neurological Disease Cancer
p-Anisic acid (4-Methoxybenzoic acid) is an orally available tyrosinase inhibitor that has antioxidant, anti-anxiety, anti-inflammatory, anti-tumor, anti-diabetic, and preservative properties. p-Anisic acid can be used as a preservative in the cosmetics field .

HY-121515

DPM-1001	Phosphatase	Metabolic Disease
DPM-1001 is a potent, specific, orally active and non-competitive inhibitor of protein-tyrosine phosphatase (PTP1B) with an IC₅₀ of 100 nM. DPM-1001 is an analog of the specific PTP1B inhibitor MSI-1436. DPM-1001 has anti-diabetic property .

HY-77490

(R)-(-)-1,3-Butanediol	Endogenous Metabolite	Metabolic Disease
(R)-(-)-1,3-Butanediol is the R-enantiomer of 1,3-Butanediol (HY-77490A). (R)-(-)-1,3-Butanediol exhibits anti-diabetic property in rats. (R)-(-)-1,3-Butanediol can be used as flavoring and fragrance agents. (R)-(-)-1,3-Butanediol is used to regulate the metabolism of carbohydrate and lipid. .

HY-N6858

4-Hydroxyisoleucine 4-Hydroxy-L-isoleucine	Others	Metabolic Disease
4-Hydroxyisoleucine is an orally active amino acid that can be isolated from fenugreek seeds. 4-Hydroxyisoleucine displays insulinotropic and antidiabetic properties .

HY-N0364

Falcarindiol 3 Publications Verification	Apoptosis Autophagy PPAR	Infection Metabolic Disease Inflammation/Immunology Cancer
Falcarindiol, an orally active polyacetylenic oxylipin, activates PPARγ and increases the expression of the cholesterol transporter ABCA1 in cells. Falcarindiol induces apoptosis and autophagy. Falcarindiol has anti-inflammatory, antifungal, anticancer and antidiabetic properties . Falcarindiol is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

HY-W984782

Flindersine	GLUT Bacterial Fungal AMPK PPAR Reactive Oxygen Species (ROS) Apoptosis SOD	Infection Metabolic Disease Cancer
Flindersine is an alkaloid with multiple activities including antibacterial, antifungal, antitumor, and antidiabetic properties. Flindersine increases the activity of antioxidant enzymes, restores the levels of renal biomarkers, and reduces blood glucose, blood lipid, and insulin levels in diabetic rats. Flindersine inhibits the growth of Gram-positive bacteria, Gram-negative bacteria, drug-resistant bacteria, as well as dermatophytes, filamentous fungi, and yeasts. Flindersine reduces the viability of cancer cells and induces apoptosis. Flindersine can be used in research related to breast cancer, type 2 diabetes, bacterial infections, and fungal infections .

HY-N6039

Gentianine 1 Publications Verification	Others	Metabolic Disease Inflammation/Immunology
Gentianine, an active metabolite of Swertiamarin, has anti-diabetic effect and anti-inflammatory property .

HY-14928A

Lobeglitazone sulfate	PPAR ERK JNK TGF-beta/Smad NO Synthase COX NF-κB Interleukin Related	Cardiovascular Disease Metabolic Disease Inflammation/Immunology
Lobeglitazone sulfate is a new type of thiazolidinedione. Lobeglitazone sulfate is the orally active agonist for PPAR with EC₅₀ of 137.4 nM and 546.3 nM for PPARγ and PPARα. Lobeglitazone sulfate is the inhibitor for ERK/JNK/Smad/NF-κB signaling pathway. Lobeglitazone sulfate exhibits anti-inflammatory, anti-diabetic, anti-fibrotic and anti-atherosclerotic properties .

HY-121515A

DPM-1001 trihydrochloride	Phosphatase	Metabolic Disease
DPM-1001 trihydrochloride is a potent, specific, orally active and non-competitive inhibitor of protein-tyrosine phosphatase (PTP1B) with an IC₅₀ of 100 nM. DPM-1001 trihydrochloride is an analog of the specific PTP1B inhibitor MSI-1436. DPM-1001 trihydrochloride has anti-diabetic property .

HY-N0828R

Pterostilbene (Standard)	Reference Standards Autophagy	Inflammation/Immunology Cancer
Pterostilbene (Standard) is the analytical standard of Pterostilbene. This product is intended for research and analytical applications. Pterostilbene is a stilbenoid isolated from blueberries and Pterocarpus marsupium . Shows anti-oxidant, anti-inflammatory, anti-carcinogenic, anti-diabetic and anti-obesity properties . Pterostilbene blocks ROS production , also exhibits inhibitory activity against various free radicals such as DPPH, ABTS, hydroxyl, superoxide and hydrogen peroxide .

HY-N0036R

Costunolide (Standard) (+)-Costunolide (Standard); Costus lactone (Standard)	Reference Standards Apoptosis Endogenous Metabolite	Cancer
Costunolide (Standard) is the analytical standard of Costunolide. This product is intended for research and analytical applications. Costunolide ((+)-Costunolide) is a naturally occurring sesquiterpene lactone, with antioxidative, anti-inflammatory, antiallergic, bone remodeling, neuroprotective, hair growth promoting, anticancer, and antidiabetic properties. Costunolide can induce cell cycle arrest and apoptosis on breast cancer cells .

HY-N9363

Corymbiferin	Others	Metabolic Disease
Corymbiferin is one of active constituents, responsible for anti-diabetic properties. Corymbiferin improves antioxidant capacity and carbohydrate metabolism in diabetic rats, along with the improvement of histopathology of livers and pancreatic β cells .

HY-110065

SER-601	Cannabinoid Receptor	Neurological Disease
SER-601 is a potent and selective peripheral cannabinoid (CB2) receptor agonist with a K_i of 6.3 nM. SER-601 has analgesic and antidiabetic properties and can be used for relevant research .

HY-N0188R

Esculin (Standard)	Reference Standards p38 MAPK	Inflammation/Immunology Cancer
Esculin (Standard) is the analytical standard of Esculin. This product is intended for research and analytical applications. Esculin is a fluorescent coumarin glucoside, the active ingredient in ash bark. Esculin has antidiabetic effects, improves cognitive impairment in experimental diabetic nephropathy (DN) via the MAPK signaling pathway, and exerts antioxidant stress and anti-inflammatory effects. Esculin also has anticancer, antibacterial, antiviral, neuroprotective, antithrombotic, and therapeutic properties for eye diseases .

HY-N2534R

Karanjin (Standard)	Reference Standards AMPK Apoptosis Cytochrome P450 Phosphatase NF-κB	Neurological Disease Metabolic Disease Inflammation/Immunology Endocrinology Cancer
Karanjin (Standard) is the analytical standard of Karanjin. This product is intended for research and analytical applications. Karanjin is an orally active furanoflavonoid which can be isolated from several Leguminosae. Karanjin exhibits evident anti-diabetic, anti-cancer, anti-inflammatory, antioxidant, anticolitis, anti-ulcer, anti-Alzheimer properties and multiple insect repellent/insecticidal, acaricide properties, suggesting the potential of Karanjin to be applied to relevant research .

HY-N0457R

Chicoric acid (Standard) Cichoric acid (Standard); Dicaffeoyltartaric acid (Standard)	Reference Standards Reactive Oxygen Species (ROS) Apoptosis	Metabolic Disease Inflammation/Immunology
Chicoric acid (Standard) is the analytical standard of Chicoric acid. This product is intended for research and analytical applications. Chicoric acid (Cichoric acid), an orally active dicaffeyltartaric acid, induces reactive oxygen species (ROS) generation. Chicoric acid inhibits cell viability and induces mitochondria-dependent apoptosis in 3T3-L1 preadipocytes through ROS-mediated PI3K/Akt and MAPK signaling pathways. Chicoric acid increases glucose uptake, improves insulin resistance, and attenuates glucosamine-induced inflammation. Chicoric acid has antidiabetic properties and antioxidant, anti-inflammatory effects .

HY-162578

PPARα/γ agonist 4	PPAR	Metabolic Disease
PPARα/γ agonist 4 (Compound (S)-7) is an orally active dual potent agonist of PPARα and PPARγ, with EC₅₀ values of 0.061 μM and 1.42 μM respectively. PPARα/γ agonist 4 acts through an insulin-independent mechanism and exhibits mitochondrial pyruvate carrier inhibition and anti-diabetic properties. PPARα/γ agonist 4 is expected to be used in research for dyslipidemic type 2 diabetes .

HY-170943

Antidiabetic agent 7	AMPK GLUT	Metabolic Disease
Antidiabetic agent 7 (Compound 5m) is hyperglycemic inhibitor. Antidiabetic agent 7 exhibits promising potency to stimulate GLUT4 translocation in skeletal muscle cells via activating AMPK-dependent pathway. Antidiabetic agent 7 reduces blood glucose levels. Antidiabetic agent 7 shows favorable pharmacokinetic properties. Antidiabetic agent 7 is potential to be used for anti-hyperglycemic research .

HY-100618R

Hispidin (Standard)	Reference Standards PKC Endogenous Metabolite Ferroptosis Reactive Oxygen Species (ROS) p38 MAPK JAK STAT JNK Akt GSK-3 ERK Keap1-Nrf2	Cardiovascular Disease Metabolic Disease Inflammation/Immunology Cancer
Hispidin (Standard) is the analytical standard of Hispidin. This product is intended for research and analytical applications. Hispidin, a PKC inhibitor and a phenolic compound can be found in Phellinus linteus, has been shown to possess strong anti-oxidant, anti-cancer, anti-diabetic, and anti-dementia properties[1][2][3][4][5][6][7].

HY-W097858

2-Hydroxy-4-methoxybenzoic acid potassium 4-Methoxysalicylic acid potassium	Tyrosinase	Infection Metabolic Disease
2-Hydroxy-4-methoxybenzoic acid (potassium), is one of the major phytoconstituents of Decalepis arayalpathra, also known as 4-Methoxysalicylic acid (potassium), has a variety of biological effects, including anti-inflammatory, antipyretic, antioxidant, and anti-diabetic properties .

HY-N6858R

4-Hydroxyisoleucine (Standard) 4-Hydroxy-L-isoleucine (Standard)	Reference Standards Others	Metabolic Disease
4-Hydroxyisoleucine (Standard) is the analytical standard of 4-Hydroxyisoleucine. This product is intended for research and analytical applications. 4-Hydroxyisoleucine is an orally active amino acid that can be isolated from fenugreek seeds. 4-Hydroxyisoleucine displays insulinotropic and antidiabetic properties .

HY-168594

α-Glucosidase/NLRP3-IN-1	Glycosidase NOD-like Receptor (NLR)	Neurological Disease Metabolic Disease
α-Glucosidase/NLRP3-IN-1 (Compound 8) is a dual inhibitor of α-glucosidase and NLRP3, exhibiting an IC₅₀ of 6.6 μM against α-glucosidase and inhibiting NLRP3 in multiple cell lines at a concentration of 100 μM. α-Glucosidase/NLRP3-IN-1 demonstrates neuroprotective and antidiabetic properties, and can be utilized in relevant research .

HY-14621R

Zingerone (Standard) Vanillylacetone (Standard); Gingerone (Standard)	Reference Standards NF-κB	Metabolic Disease Inflammation/Immunology Cancer
Zingerone (Standard) is the analytical standard of Zingerone. This product is intended for research and analytical applications. Zingerone (Vanillylacetone) is a nontoxic methoxyphenol isolated from Zingiber officinale, with potent anti-inflammatory, antidiabetic, antilipolytic, antidiarrhoeic, antispasmodic and anti-tumor properties . Zingerone alleviates oxidative stress and inflammation, down-regulates NF-κB mediated signaling pathways . Zingerone acts as an anti-mitotic agent, and inhibits the growth of neuroblastoma cells .

HY-B0920R

Tolazamide (Standard) U-17835 (Standard)	Reference Standards Potassium Channel	Metabolic Disease Endocrinology
Tolazamide (U-17835) (Standard) is the analytical standard of Tolazamide. This product is intended for research and analytical applications. Tolazamide is an orally active sulfonylurea agent that inhibits sulfonylurea receptor 1 (SUR1) linked to the inwardly rectifying potassium channel (IC₅₀ = 4.2 µM in HEK293 cells transfected with the human receptor). Tolazamide has anti-diabetic properties. Tolazamide can lower blood glucose in sulfonylurea class. Tolazamide decreases insulin dose while continuing to maintain adequate metabolic control. Tolazamide is able to improve or normalize hyperglycemia and HbA .

HY-105608

Narceine Narcein	Others	Metabolic Disease
Narceine (Narcein), a quinolone derivative, is an opium alkaloid with anti-diabetic property .

HY-N18753

Salacia reticulata extract	Others	Metabolic Disease Inflammation/Immunology
Salacia reticulata extract is derived from the roots of Salacia reticulata and possesses anti-diabetic, anti-inflammatory, and antioxidant properties. The active constituents of Salacia reticulata extract include salacinol, kotalanol, and flavonoids.

HY-N18702

Pterocarpus marsupium extract	Others	Metabolic Disease Inflammation/Immunology
Pterocarpus marsupium extract is derived from the bark of the Indian rosewood tree. Its active ingredients include pterostilbene, santalin, flavonoids, and tannins, which give it antioxidant, anti-inflammatory, anti-diabetic, and cardioprotective properties.

HY-N18688

Gymnema sylvestre extract	Others	Metabolic Disease
Gymnema sylvestre extract, derived from the leaves of the Gymnema sylvestre plant, is renowned for its anti-diabetic and blood sugar-regulating properties. The key active compounds in the extract are gymnemic acids, which are responsible for its ability to block the taste of sweetness and reduce sugar absorption in the intestines.

HY-N19039

Aerva lanata extract	Bacterial	Infection Metabolic Disease Inflammation/Immunology
Aerva Lanata Extract is a versatile herbal extract with a wide range of bioactive compounds and medicinal properties. Aerva Lanata Extract contains various phytochemicals such as flavonoids, terpenoids, alkaloids, tannins, and phenolic compounds. Aerva Lanata Extract shows significant antioxidant, antimicrobial, anti-cancer, anti-inflammatory, and anti-diabetic activities.

HY-N18751

Aegle marmelos extract	Bacterial	Inflammation/Immunology
Aegle marmelos extract, derived from the Aegle marmelos plant, is rich in various bioactive compounds, such as coumarins (e.g., ligustin, ligustin, ligustin, psoralen, scopolamine, and umbelliferone), flavonoids, phenolic acids, and terpenoids. Aegle marmelos extract possesses anti-inflammatory, antibacterial, antioxidant, antiviral, antifungal, antitumor, and antidiabetic properties.

HY-W723952

p-Anisic acid-d7 4-Methoxybenzoic acid-d₇; Draconic acid-d₇	Isotope-Labeled Compounds Bacterial Tyrosinase Endogenous Metabolite	Cancer
p-Anisic acid-d₇ (4-Methoxybenzoic acid-d₇) is the deuterium labeled p-Anisic acid (HY-N1394). p-Anisic acid (4-Methoxybenzoic acid) is an orally available tyrosinase inhibitor that has antioxidant, anti-anxiety, anti-inflammatory, anti-tumor, anti-diabetic, and preservative properties. p-Anisic acid can be used as a preservative in the cosmetics field .

HY-P11629

KBP-336	Amylin Receptor CGRP Receptor	Neurological Disease Metabolic Disease Inflammation/Immunology
KBP-336 is a dual amylin and calcitonin receptor agonist (DACRA). KBP-336 exhibits antidiabetic and insulin-sensitizing properties, improves glucose levels, spatial learning, and memory in diabetic rats, and reduces blood glucose. KBP-336 also alleviates pain-like symptoms in osteoarthritis rats. KBP-336 also promotes weight and fat reduction. KBP-336 is useful for research on diabetes, obesity, and arthritis .

HY-N18656

Terminalia chebula extract	Bacterial	Infection
Terminalia chebula extract, derived from the fruit of the Terminalia chebula tree. Rich in bioactive compounds such as tannins, flavonoids, phenols, and organic acids like gallic acid and ellagic acid, this extract demonstrates a wide range of pharmacological activities. It acts as a natural laxative, supports digestive health, and exhibits potent antioxidant, anti-inflammatory, and antibacterial properties, effectively targeting various pathogenic bacteria, including Helicobacter pylori, Staphylococcus aureus, and Escherichia coli. Terminalia Chebula Extract also shows significant hepatoprotective effects, shielding the liver from damage through antioxidant and anti-inflammatory mechanisms. It has nephroprotective properties, alleviating renal dysfunction and enhancing kidney health by modulating inflammatory pathways. Additionally, the extract demonstrates neuroprotective activity, reducing neuronal damage and improving memory function. It has potential anti-diabetic effects, enhancing glucose uptake and reducing oxidative stress.

HY-N17771

(6-O-p-Coumaroyl)-β-D-glucopyranosyl-2-O-(4-hydroxybenzoyl)-4-O-β-D-glucopyranosyl-6-hydroxyphenylacetate	Endogenous Metabolite	Metabolic Disease
(6-O-p-Coumaroyl)-β-D-glucopyranosyl-2-O-(4-hydroxybenzoyl)-4-O-β-D-glucopyranosyl-6-hydroxyphenylacetate is a selective α-glucosidase inhibitor (IC₅₀=10.53 μg/mL) with anti-hepatic fibrosis and *anti-diabetic* properties. It also inhibits the growth of mouse hepatic stellate cells (t-HSC/Cl-6) with an IC₅₀ of 109.2 μg/mL. (6-O-p-Coumaroyl)-β-D-glucopyranosyl-2-O-(4-hydroxybenzoyl)-4-O-β-D-glucopyranosyl-6-hydroxyphenylacetate can be isolated from the ester derivatives of Impatiens balsamina L. flowers. (6-O-p-Coumaroyl)-β-D-glucopyranosyl-2-O-(4-hydroxybenzoyl)-4-O-β-D-glucopyranosyl-6-hydroxyphenylacetate can be used in research related to hepatic fibrosis and type 2 diabetes.

Cat. No.	Product Name	Target	Research Area